Mizuho Securities USA’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-343,498
| Closed | -$3.86M | – | 636 |
|
|
2024
Q2 | $3.86M | Buy |
343,498
+12,498
| +4% | +$141K | 0.09% | 215 |
|
|
2024
Q1 | $3.64M | Sell |
331,000
-191,030
| -37% | -$2.1M | 0.09% | 55 |
|
|
2023
Q4 | $5.69M | Buy |
522,030
+32,048
| +7% | +$349K | 0.13% | 30 |
|
|
2023
Q3 | $5.22M | Buy |
489,982
+51,557
| +12% | +$549K | 0.16% | 50 |
|
|
2023
Q2 | $4.59M | Buy |
438,425
+135,675
| +45% | +$1.42M | 0.15% | 50 |
|
|
2023
Q1 | $3.07M | Buy |
302,750
+1
| +0% | +$10 | 0.18% | 76 |
|
|
2022
Q4 | $3.04M | Buy |
+302,749
| New | +$3.04M | 0.28% | 65 |
|